This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
எங்கள் score நீண்டகால performance, risk மற்றும் consistency-ஐ மதிப்பிடுகிறது — past returns மட்டும் அல்ல.
4 Nov 2026 நிலவரப்படி
31 Oct 2026 நிலவரப்படி
30 Sep 2026 நிலவரப்படி
| Holding | Fund-இன் % | மதிப்பு | பங்குகள் |
|---|---|---|---|
| iShares NASDAQ 100 UCITS ETF USD | 16.33% | ₹701.11 Cr | 41,550 |
| Eternal Ltd. | 5.53% | ₹237.55 Cr | 74,23,324 |
| INDO-MIM Ltd. | 4.92% | ₹211.22 Cr | 17,00,000 |
| Lenskart Solutions Ltd. | 3.65% | ₹156.82 Cr | 22,89,184 |
| Aster DM Quality Care Ltd. | 2.94% | ₹126.21 Cr | 18,10,427 |
| Aditya Infotech Ltd. | 2.90% | ₹124.73 Cr | 3,24,277 |
| ICICI Bank Ltd. | 2.66% | ₹114.33 Cr | 8,65,000 |
| Interglobe Aviation Ltd. | 2.41% | ₹103.42 Cr | 2,07,500 |
| Capillary Technologies India Ltd. | 2.15% | ₹92.51 Cr | 16,50,570 |
| Bharti Hexacom Ltd. | 2.05% | ₹88.21 Cr | 6,19,250 |
Long term capital growth. Investment in equity and equity related securities of companies operating with pioneering innovations theme without any market capitalisation and sector bias.
The scheme seeks to generate capital appreciation from a diversified portfolio of equity, equity related instruments and units of global mutual funds which invests into such companies that utilize new forms of production, technology, distribution or processes which are likely to challenge existing markets or value networks, or displace established market leaders, or bring in novel products and/or business models.
0.5% for redemption within 90 Days
மியூச்சுவல் ஃபண்டுகள் சந்தை ஆபத்துகளுக்கு உட்பட்டவை. அனைத்து scheme documents-ஐ கவனமாகப் படிக்கவும்.
